539730 Stock Overview
Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, CIS countries, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Fredun Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹673.70 |
| 52 Week High | ₹1,054.00 |
| 52 Week Low | ₹650.00 |
| Beta | 1.33 |
| 11 Month Change | -7.31% |
| 3 Month Change | -15.56% |
| 1 Year Change | -23.27% |
| 33 Year Change | 35.69% |
| 5 Year Change | 230.73% |
| Change since IPO | 5,289.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539730 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.6% | 0.5% | 0.5% |
| 1Y | -23.3% | 42.5% | 27.5% |
Return vs Industry: 539730 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 539730 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 539730 volatility | |
|---|---|
| 539730 Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 539730 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 539730's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 256 | Daulat Medhora | www.fredungroup.com |
Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, and other healthcare products in India, Africa, Southeast Asia, CIS countries, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, anti-bacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, antibacterial, analgesics, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It provides surgical products, such as IV fluids and cannula, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products.
Fredun Pharmaceuticals Limited Fundamentals Summary
| 539730 fundamental statistics | |
|---|---|
| Market cap | ₹3.17b |
| Earnings (TTM) | ₹176.89m |
| Revenue (TTM) | ₹3.90b |
17.9x
P/E Ratio0.8x
P/S RatioIs 539730 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539730 income statement (TTM) | |
|---|---|
| Revenue | ₹3.90b |
| Cost of Revenue | ₹3.03b |
| Gross Profit | ₹869.02m |
| Other Expenses | ₹692.13m |
| Earnings | ₹176.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.64 |
| Gross Margin | 22.27% |
| Net Profit Margin | 4.53% |
| Debt/Equity Ratio | 104.8% |
How did 539730 perform over the long term?
See historical performance and comparison